News | May 25, 2023
JB Pharma records revenue growth of 22% to Rs. 762 Cr
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The USFDA had classified Strides Puducherry facility as OAI in May 2019 followed by issuing a warning letter to this site in July 2019.
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
The collaboration between CORONA and Ferring will cater to patients across India
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
Subscribe To Our Newsletter & Stay Updated
